BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 27 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,658 | -1.5% | 50,882,000 | 0.0% | 0.07% | +9.5% |
| Q2 2023 | $51,406 | -4.2% | 50,882,000 | -0.6% | 0.06% | -10.0% |
| Q1 2023 | $53,645 | -94.7% | 51,188,000 | – | 0.07% | +6900.0% |
| Q1 2022 | $1,006,000 | -85.5% | 0 | -100.0% | 0.00% | -85.7% |
| Q4 2021 | $6,961,000 | -49.1% | 6,642,000 | -51.1% | 0.01% | -53.3% |
| Q3 2021 | $13,674,000 | -4.3% | 13,595,000 | -4.2% | 0.02% | -6.2% |
| Q2 2021 | $14,293,000 | – | 14,195,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT CAPITAL MANAGEMENT /DE/ | 70,652,000 | $71,212,000 | 1.38% |
| SHENKMAN CAPITAL MANAGEMENT INC | 14,821,000 | $14,947,000 | 1.36% |
| AQR Arbitrage LLC | 21,650,000 | $21,800,000 | 0.61% |
| Worth Venture Partners, LLC | 708,000 | $714,000 | 0.27% |
| LOOMIS SAYLES & CO L P | 2,366,716 | $197,478,000 | 0.24% |
| MACKAY SHIELDS LLC | 24,500,000 | $24,670,000 | 0.23% |
| CAMDEN ASSET MANAGEMENT L P /CA | 2,500,000 | $2,505,000 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,429,000 | $2,442,000 | 0.06% |
| Alberta Investment Management Corp | 5,500,000 | $5,545,000 | 0.05% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,900,000 | $1,913,000 | 0.04% |